-
$BYND puts from Friday entry $3 to $6.6 -$aapl puts stopped out this morning entry at $2.30 and$SHOP gave $1 from $2.75 to $3.75 rest stopped out - IF you know your levels, trading is fun “$SPX$SPY$ES$AAPL$BYND$AMZN$GOOGL$GOOG$TSLA$NOW$SHOP$REGN$ROKU$IBB$XBI “pic.twitter.com/gcaC7QL33f
-
-
OptionAlarm provides Option Swing Trade Alerts With REAL Results! Try It For 10 Days: http://ow.ly/nE5i30qc9R5 It's FREE! No Credit Card Required!
$SQ$PYPL$CRM$REGN -
Optimus v4 2020-02-03 12:40 EST. *Closed/Sold Existing:
$REGN at $340.71 for 8.72 profit (2.63%). Regeneron Pharmaceuticals, Inc (CORP). Trade Id: 34095182003022377. (P&L not vailable due to system upgrades) Stats: https://deustrader.com/optimus_mixus4.html … -
Feb 03 Monday,
$REGN is $342.59 Bearish target $336.53 -
$MRK$SNY$BAYRY$REGN: Will Eylea & Dupixent Drive Regeneron’s (REGN) Q4 Earnings?: https://www.StockNewsWires.com/mrk-sny-bayry-regn-will-eylea-dupixent-drive-regenerons-regn-q4-earnings/ … -
$MRK$BMY$REGN$XLRN: Factors Setting the Tone for Bristol-Myers (BMY) Q4 Earnings: https://www.StockNewsWires.com/mrk-bmy-regn-xlrn-factors-setting-the-tone-for-bristol-myers-bmy-q4-earnings/ … -
$PFE$NVS$GSK$REGN: Is a Disappointment in Store for Glaxo’s (GSK) Q4 Earnings?: https://www.StockNewsWires.com/pfe-nvs-gsk-regn-is-a-disappointment-in-store-for-glaxos-gsk-q4-earnings/ … -
A Beginner’s Guide to Stock Investing. On Amazon. Link: https://www.amazon.com/Beginners-Guide-Stock-Investing-Getting-ebook/dp/B07FTXYXKJ/ref=sr_1_1?ie=UTF8&qid=1532939123&sr=8-1&keywords=rocco+capici …
$PPL$PX$PFG$PG$PGR$PLD$PRU$PEG$PSA$PHM$PVH$QRVO$PWR$QCOM$DGX$RJF$RTN$O$RHT$REG$REGN$RF$RSG$RMD$RHI$ROK$COL$ROP$ROST$RCL$CRM$SBAC$SCG$SLB$STX$SEE$SRE$SHW$SPGpic.twitter.com/Lmrpz2auQm
-
$REGN is expected to announce a review of 2019 performance on 6th Feb, 2020. Higher accruals in a firm’s reported earnings, poorer future earnings. see http://www.financial-education-hub.com/1/REGN -
Punched hard today by
$SWK$GOOGL$AAPL$REGN$DJI Stupid sell off for#coronaviruspic.twitter.com/DJD2xUUzB3 -
Long
$REGN. Target: $349. -
$MRK$GSK$REGN$GILD: Will Strong HIV Sales Drive Gilead’s (GILD) Q4 Earnings?: https://www.StockNewsWires.com/mrk-gsk-regn-gild-will-strong-hiv-sales-drive-gileads-gild-q4-earnings/ … -
We are closing in on initial QQQ support as I see it; we could drop another 7-9 points from here
$SPY$QQQ$NDX$DIA$IWM$NFLX$FB$INTC$SMH$AAPL$NVDA$TSLA$ES$YM$AMZN$BA$GS$JPM$IBM$LRCX$C$GOOG$AMD$DPZ$WYNN$REGN$BIIB$IYT$MU$VXX$TVIX$C$WFC$LULU$ROKUpic.twitter.com/ciDSzu06t3
-
How
#pharma companies are responding to the#coronavirus outbreak https://cnb.cx/2TZFP9a$MRNA$REGN$VIR$GILD#biotech
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.